An Orally Active Galectin-3 Antagonist Inhibits Lung Adenocarcinoma Growth and Augments Response to PD-L1 Blockade (original) (raw)
Related papers
Inhibition of galectins in cancer: Biological challenges for their clinical application
Frontiers in Immunology
Development of Galectin-3 Targeting Drugs for Therapeutic Applications in Various Diseases
International Journal of Molecular Sciences
Role of galectin-3 in tumour metastasis
Moscow University Chemistry Bulletin, 2010
Extracellular and intracellular small-molecule galectin-3 inhibitors
Scientific Reports, 2019
Galectin-3 as a Potential Target to Prevent Cancer Metastasis
Clinical Medicine Insights: Oncology, 2015
Anti-Galectin Compounds as Potential Anti-Cancer Drugs
Current Medicinal Chemistry, Véronique Mathieu
Anticancer research
Galectin-3: A factotum in carcinogenesis bestowing an archery for prevention
Tumor Biology
Galectins as Molecular Targets for Therapeutic Intervention
International journal of molecular sciences, 2018
Clinical & Experimental Metastasis, 2014
Galectin-3: a potential target for cancer prevention
Trends in carbohydrate research, 2011
Glycoconjugate Journal, 2000
Galectin-3 Binding and Metastasis
Metastasis Research Protocols
Clinical Significance of Galectin-3 Expression in Squamous Cell Carcinoma of Lung
Role of Galectin-3 in Cancer Metastasis
Glycobiology Insights, 2015
Galectin-3 in angiogenesis and metastasis
Glycobiology, 2014
The role of galectin-3 in cancer drug resistance
Drug Resistance Updates, 2007
Archives of Gynecology and Obstetrics, 2019
Down-regulation of galectin-3 suppresses tumorigenicity of human breast carcinoma cells
Clinical cancer research : an official journal of the American Association for Cancer Research, 2001
7. Galectins- potential targets for cancer therapy
Clinical relevance of galectin-1 expression in non-small cell lung cancer patients
Lung Cancer, 2014
Role of galectin 3 binding protein in cancer progression: a potential novel therapeutic target
Journal of Translational Medicine
Galectins–potential targets for cancer therapy
Cancer letters, 2007
Impact of Galectins in Resistance to Anticancer Therapies
Clinical Cancer Research, 2020
Galectin-3: multiple clinical applications
Biomedical Reviews
Molecular Biology Reports, 2021
Oncotarget, 2015